Medicine
Cabergoline
Each fact is a quote from a trusted source. Published 2026-11-17.
These pages do not diagnose conditions.
These pages do not give doses or medicine-taking instructions.
Facts
medicine group: Cabergoline is classified as a chemical agent.
Medicine type Chemical agent
WHO Electronic Essential Medicines List (eEML)what it is used for: Cabergoline is indicated for the treatment of Parkinson disease.
Indications Parkinson disease
WHO Electronic Essential Medicines List (eEML)what it is used for: Cabergoline is indicated for other specified benign neoplasms of endocrine glands.
Indications Other specified benign neoplasm of endocrine glands
WHO Electronic Essential Medicines List (eEML)essential medicine status: Cabergoline was added to the essential medicines list in 2023 for other specified benign neoplasms of endocrine glands.
Added in 2023 ( TRS 1049 ) for Other specified benign neoplasm of endocrine glands
WHO Electronic Essential Medicines List (eEML)what it is: Cabergoline is an ergoline derivative and a dopamine D2-agonist.
An ergoline derivative and dopamine D2-agonist that inhibits PROLACTIN secretion.
Medical Subject Headings (NLM, NIH)medicine group: Cabergoline is classified as an antiparkinson agent and a dopamine agonist.
Pharm Action Antiparkinson Agents Dopamine Agonists
Medical Subject Headings (NLM, NIH)what it is used for: Cabergoline is used to manage hyperprolactinemia, suppress lactation after childbirth for medical reasons, and manage Parkinson disease.
It is used in the management of HYPERPROLACTINEMIA , and to suppress lactation following childbirth for medical reasons. Cabergoline is also used in the management of PARKINSON DISEASE .
Medical Subject Headings (NLM, NIH)how it works: Cabergoline acts by inhibiting the secretion of prolactin.
An ergoline derivative and dopamine D2-agonist that inhibits PROLACTIN secretion.
Medical Subject Headings (NLM, NIH)
Sources
- eEML - Electronic Essential Medicines List
WHO Electronic Essential Medicines List (eEML) · retrieved 2026-11-15
- MeSH Browser
Medical Subject Headings (NLM, NIH) · retrieved 2026-11-15